Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Hippocampal function and schizophrenia. Experimental psychological evidence.

Literature DB >> 1497255

Hippocampal function and schizophrenia. Experimental psychological evidence.

P H Venables¹.

Abstract

Entities: Disease

Mesh：

Year: 1992 PMID： 1497255 DOI： 10.1111/j.1749-6632.1992.tb22841.x

Source DB: PubMed Journal: Ann N Y Acad Sci ISSN： 0077-8923 Impact factor: 5.691

Keyword Cloud
Cited

× No keyword cloud information.

20 in total

Review 1. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

Authors: Paul J Harrison
Journal: Psychopharmacology (Berl) Date: 2004-03-06 Impact factor: 4.530

2. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.

Authors: Karen E Stevens; Brandon Cornejo; Catherine E Adams; Lijun Zheng; Joan Yonchek; Keith L Hoffman; Uwe Christians; William R Kem
Journal: Brain Res Date: 2010-07-03 Impact factor: 3.252

Review 3. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.

Authors: Daniel J Lodge; Anthony A Grace
Journal: Neurotox Res Date: 2008-10 Impact factor: 3.911

Review 4. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

Authors: Ann Olincy; Karen E Stevens
Journal: Biochem Pharmacol Date: 2007-07-17 Impact factor: 5.858

5. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains.

Authors: D Barbeau; J J Liang; Y Robitalille; R Quirion; L K Srivastava
Journal: Proc Natl Acad Sci U S A Date: 1995-03-28 Impact factor: 11.205

6. Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.

Authors: Karen E Stevens; Kevin S Choo; Jerry A Stitzel; Michael J Marks; Catherine E Adams
Journal: Brain Res Date: 2014-01-23 Impact factor: 3.252

Hippocampal function and schizophrenia. Experimental psychological evidence.

Review 1. The hippocampus in schizophrenia: a review of the neuropathological evidence and its pathophysiological implications.

2. Continuous administration of a selective alpha7 nicotinic partial agonist, DMXBA, improves sensory inhibition without causing tachyphylaxis or receptor upregulation in DBA/2 mice.

Review 3. Hippocampal dysfunction and disruption of dopamine system regulation in an animal model of schizophrenia.

Review 4. Treating schizophrenia symptoms with an alpha7 nicotinic agonist, from mice to men.

5. Decreased expression of the embryonic form of the neural cell adhesion molecule in schizophrenic brains.

6. Long-term improvements in sensory inhibition with gestational choline supplementation linked to α7 nicotinic receptors through studies in Chrna7 null mutation mice.

Review 7. Limbic and cortical information processing in the nucleus accumbens.

8. Stimulation of the alpha4beta2 nicotinic receptor by 5-I A-85380 improves auditory gating in DBA/2 mice.

Review 9. Alpha-7 nicotinic receptor agonists: potential new candidates for the treatment of schizophrenia.

10. Permanent improvement in deficient sensory inhibition in DBA/2 mice with increased perinatal choline.